findmyKOL
Clinical trialNCT05558371RecruitingObservational

International CDKL5 Clinical Research Network

SponsorUniversity of Colorado, DenverEnrollment1,000CDDCDKL5CDKL5 Deficiency Disorder
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Pathogenic variants in the Cyclin-dependent kinase like 5 (CDKL5) gene cause CDKL5 deficiency disorder (CDD, MIM 300672, 105830), a severe developmental and epileptic encephalopathy associated with cognitive and motor impairments and cortical visual impairment. While capability for disease modifying therapies is accelerating, there is a critical barrier for clinical trial readiness that may result in failure of these therapies, not due to lack of efficacy but due to lack of validated outcome measures and biomarkers. The measures and biomarkers validated here will be adaptable to other developmental and epileptic encephalopathies.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Telethon Kids Institute/perth Children'S Hospital

    Perth, Nedlands Western Australia, Australia

    Helen Leonard, MPHJenny Downs, PhD
    Recruiting
United States
  • University of California Los Angeles/ucla Mattel Children'S Hospital

    Los Angeles, California, United States

    Rajsekar Rajaraman, MD
    Recruiting
  • University of Colorado Denver/children'S Hospital Colorado

    Aurora, Colorado, United States

    Scott T Demarest, MD MSCSTimothy A Benke, MD PhD
    Recruiting
  • Harvard Medical School/boston Children'S Hospital

    Boston, Massachusetts, United States

    Heather E Olson, MDWill Hong, MD
    Recruiting
  • Washington University in St. Louis/st. Louis Children'S Hospital

    St Louis, Missouri, United States

    Judith Weisenberg, MD
    Recruiting
  • Nyu Langone Health

    New York, New York, United States

    Dana Price, MD
    Recruiting
  • Cleveland Clinic Foundation

    Cleveland, Ohio, United States

    Elia Pestana Knight, MD
    Recruiting
  • Children'S Hospital of Philadelphia

    Philadelphia, Pennsylvania, United States

    Eric Marsh, MD PhDErin Prange, MSN CRNP
    Recruiting
  • Baylor College of Medicine/ Texas Children'S Hospital

    Houston, Texas, United States

    Bernhard Suter
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 Feb 2021
Primary completion
15 Feb 2026
Completion
15 Feb 2027
Last update posted
6 Dec 2023
Registered enrollment
1,000
Registry id
NCT05558371

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.